Moray Medical, a Mountain View, CA-based interventional robotics startup, closed $5.7M in seed financing.
Backers included 415 Capital (lead), Heal Capital, as well as a number of medtech entrepreneurs, such as Fred St. Goar, MD, inventor of the MitralClip™ transcatheter mitral valve repair (TMVR) system.
The company will use the funding to continue development of its CoralTMsystem.
Led by Mark Barrish, CEO and Co-Founder, Moray Medical provides Coral, an innovative interventional robotics platform powered by microfluidics and an augmented reality (AR) digital user interface. While the platform promises to simplify a wide range of minimally invasive cardiovascular interventions, Moray Medical is initially focused on the transcatheter mitral valve repair (TMVR) market.
FinSMEs
13/04/2021